Compare Amylx Pharmaceuticals Inc (AMLX) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs First Citizens BancShares Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $22.57 (market cap $2.60B), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc is far larger — about 9.7× Amylx Pharmaceuticals Inc's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | FCNCA | |
|---|---|---|
Market Cap | $2.60B | $25.26B |
Sector | Health | Sector/Thematic |
52-Week High | $24.19 | $2.27K |
52-Week Low | $7.82 | $1.64K |
Enterprise Value | $2.36B | — |
Dividend Yield | — | 0.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
